THE USE OF SERUM MARKER WFA+-M2BP FOR EVALUATION OF FIBROSIS AND CIRRHOTIC AFFECTION OF LIVER AT HCV INDUCED HEPATITISES

Authors

Publication Details

Published
2024-12-19
DOI
https://doi.org/10.34660/inf.2019.9.31271
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

THE USE OF SERUM MARKER WFA+-M2BP FOR EVALUATION OF FIBROSIS AND CIRRHOTIC AFFECTION OF LIVER AT HCV INDUCED HEPATITISES

I. N. Egamova, N.N. Volkova
Liver Disease Diagnosis and Treatment
article

THE USE OF SERUM MARKER WFA+-M2BP FOR EVALUATION OF FIBROSIS AND CIRRHOTIC AFFECTION OF LIVER AT HCV INDUCED HEPATITISES

I. N. Egamova, N.N. Volkova
article en

Abstract

No abstract available for this paper.
United Nations Educational, Scientific and Cultural Organization, Ministry of Health of the Russian Federation, Academy of Military Medical Sciences
Good health and well-being
Openalex Percentile: Top 65%
Liver Disease Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

THE USE OF SERUM MARKER WFA+-M2BP FOR EVALUATION OF FIBROSIS AND CIRRHOTIC AFFECTION OF LIVER AT HCV INDUCED HEPATITISES — I. N. Egamova, N.N. Volkova · (2024) | TGRS Research Map | TGRS